Ventura County Hematology Oncology Specialists will use Deep Lens’ solution to expand its clinical trial offerings. Credit: National Cancer Institute on Unsplash.

Ventura County Hematology Oncology Specialists has signed an agreement to integrate Deep Lens’ clinical trial matching solution which is based on artificial intelligence (AI).

The practice will also use Deep Lens’ other services as part of the collaboration.

Deep Lens’ software will help in identifying eligible participants for clinal trials effectively and quickly.

It automates the process to identify potentially eligible subjects during diagnosis and then match them to relevant clinical trials.

The AI-based solution will pre-screen the participants from EMR (OncoEMR) of Ventura County Hematology Oncology Specialists and merge the molecular data feeds from Foundation Medicine, Guardant Health, and all pathology feeds for automatic identification of qualified participants for the clinical trials.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Deep Lens sales provider and vice-president Tyrone Richardson said: “The majority of patients diagnosed with cancer are treated by community oncologists, and it is critical to bring more trials to this setting so that patients can receive access to novel therapies in a comfortable, familiar environment, without having to travel or commute to larger medical centres.

“Ventura is a great example of a community oncology practice that prioritizes clinical research and we’re delighted that we can add value to their program and help more of their patients receive stellar, cutting- edge care.”

The company stated that its pre-screening and clinical trial matching solution is provided to oncology practices for free.

Recently, Deep Lens launched its new Real Time Feasibility tool designed to identify eligible patients and select the efficient study sites in the Deep Lens Unity Network for cancer clinical trials.